These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

458 related articles for article (PubMed ID: 15585108)

  • 21. Intradermal injection of lentiviral vectors corrects regenerated human dystrophic epidermolysis bullosa skin tissue in vivo.
    Woodley DT; Keene DR; Atha T; Huang Y; Ram R; Kasahara N; Chen M
    Mol Ther; 2004 Aug; 10(2):318-26. PubMed ID: 15294178
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Histological and molecular restoration of type VII collagen in Recessive dystrophic epidermolysis bullosa mouse skin by topical injection of keratinocyte-like cells differentiated from human adipose-derived mesenchymal stromal cells.
    Matsuda A; Hasegawa T; Ikeda Y; Wada A; Ikeda S
    J Dermatol Sci; 2024 Jul; 115(1):42-50. PubMed ID: 38876908
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Keratinocyte cell lines derived from severe generalized recessive epidermolysis bullosa patients carrying a highly recurrent COL7A1 homozygous mutation: models to assess cell and gene therapies in vitro and in vivo.
    Chamorro C; Almarza D; Duarte B; Llames SG; Murillas R; García M; Cigudosa JC; Espinosa-Hevia L; Escámez MJ; Mencía A; Meana A; García-Escudero R; Moro R; Conti CJ; Del Río M; Larcher F
    Exp Dermatol; 2013 Sep; 22(9):601-3. PubMed ID: 23947675
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Long-term follow-up of patients with recessive dystrophic epidermolysis bullosa in the Netherlands: expansion of the mutation database and unusual phenotype-genotype correlations.
    van den Akker PC; van Essen AJ; Kraak MM; Meijer R; Nijenhuis M; Meijer G; Hofstra RM; Pas HH; Scheffer H; Jonkman MF
    J Dermatol Sci; 2009 Oct; 56(1):9-18. PubMed ID: 19665875
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Translating the combination of gene therapy and tissue engineering for treating recessive dystrophic epidermolysis bullosa.
    Dakiw Piaceski A; Larouche D; Ghani K; Bisson F; Cortez Ghio S; Larochelle S; Moulin VJ; Caruso M; Germain L
    Eur Cell Mater; 2018 Feb; 35():73-86. PubMed ID: 29441510
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Therapeutic base editing and prime editing of COL7A1 mutations in recessive dystrophic epidermolysis bullosa.
    Hong SA; Kim SE; Lee AY; Hwang GH; Kim JH; Iwata H; Kim SC; Bae S; Lee SE
    Mol Ther; 2022 Aug; 30(8):2664-2679. PubMed ID: 35690907
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Stable nonviral genetic correction of inherited human skin disease.
    Ortiz-Urda S; Thyagarajan B; Keene DR; Lin Q; Fang M; Calos MP; Khavari PA
    Nat Med; 2002 Oct; 8(10):1166-70. PubMed ID: 12244305
    [TBL] [Abstract][Full Text] [Related]  

  • 28. An RNA-targeted therapy for dystrophic epidermolysis bullosa.
    Peking P; Koller U; Duarte B; Murillas R; Wolf S; Maetzig T; Rothe M; Kocher T; García M; Brachtl G; Schambach A; Larcher F; Reichelt J; Bauer JW; Murauer EM
    Nucleic Acids Res; 2017 Sep; 45(17):10259-10269. PubMed ID: 28973459
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Intravenously Administered Recombinant Human Type VII Collagen Derived from Chinese Hamster Ovary Cells Reverses the Disease Phenotype in Recessive Dystrophic Epidermolysis Bullosa Mice.
    Hou Y; Guey LT; Wu T; Gao R; Cogan J; Wang X; Hong E; Vivian Ning W; Keene D; Liu N; Huang Y; Kaftan C; Tangarone B; Quinones-Garcia I; Uitto J; Francone OL; Woodley DT; Chen M
    J Invest Dermatol; 2015 Dec; 135(12):3060-3067. PubMed ID: 26203639
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Keratinocyte-/fibroblast-targeted rescue of Col7a1-disrupted mice and generation of an exact dystrophic epidermolysis bullosa model using a human COL7A1 mutation.
    Ito K; Sawamura D; Goto M; Nakamura H; Nishie W; Sakai K; Natsuga K; Shinkuma S; Shibaki A; Uitto J; Denton CP; Nakajima O; Akiyama M; Shimizu H
    Am J Pathol; 2009 Dec; 175(6):2508-17. PubMed ID: 19893033
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Aminoglycosides restore full-length type VII collagen by overcoming premature termination codons: therapeutic implications for dystrophic epidermolysis bullosa.
    Cogan J; Weinstein J; Wang X; Hou Y; Martin S; South AP; Woodley DT; Chen M
    Mol Ther; 2014 Oct; 22(10):1741-52. PubMed ID: 25155989
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Human Mesenchymal Stromal Cells Engineered to Express Collagen VII Can Restore Anchoring Fibrils in Recessive Dystrophic Epidermolysis Bullosa Skin Graft Chimeras.
    Petrova A; Georgiadis C; Fleck RA; Allison L; McGrath JA; Dazzi F; Di WL; Qasim W
    J Invest Dermatol; 2020 Jan; 140(1):121-131.e6. PubMed ID: 31326396
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Injection of genetically engineered fibroblasts corrects regenerated human epidermolysis bullosa skin tissue.
    Ortiz-Urda S; Lin Q; Green CL; Keene DR; Marinkovich MP; Khavari PA
    J Clin Invest; 2003 Jan; 111(2):251-5. PubMed ID: 12531881
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Characterization of mutant type VII collagens underlying the inversa subtype of recessive dystrophic epidermolysis bullosa.
    Woodley DT; Cogan J; Mosallaei D; Yim K; Chen M
    J Dermatol Sci; 2021 Nov; 104(2):104-111. PubMed ID: 34674926
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Monozygotic twins discordant for recessive dystrophic epidermolysis bullosa phenotype highlight the role of TGF-β signalling in modifying disease severity.
    Odorisio T; Di Salvio M; Orecchia A; Di Zenzo G; Piccinni E; Cianfarani F; Travaglione A; Uva P; Bellei B; Conti A; Zambruno G; Castiglia D
    Hum Mol Genet; 2014 Aug; 23(15):3907-22. PubMed ID: 24599399
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Development of Minicircle Vectors Encoding COL7A1 Gene with Human Promoters for Non-Viral Gene Therapy for Recessive Dystrophic Epidermolysis Bullosa.
    Wang X; Alshehri F; Manzanares D; Li Y; He Z; Qiu B; Zeng M; A S; Lara-Sáez I; Wang W
    Int J Mol Sci; 2021 Nov; 22(23):. PubMed ID: 34884578
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The development of induced pluripotent stem cell-derived mesenchymal stem/stromal cells from normal human and RDEB epidermal keratinocytes.
    Nakayama C; Fujita Y; Matsumura W; Ujiie I; Takashima S; Shinkuma S; Nomura T; Abe R; Shimizu H
    J Dermatol Sci; 2018 Sep; 91(3):301-310. PubMed ID: 29933899
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Induced pluripotent stem cells from individuals with recessive dystrophic epidermolysis bullosa.
    Tolar J; Xia L; Riddle MJ; Lees CJ; Eide CR; McElmurry RT; Titeux M; Osborn MJ; Lund TC; Hovnanian A; Wagner JE; Blazar BR
    J Invest Dermatol; 2011 Apr; 131(4):848-56. PubMed ID: 21124339
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Development and characterization of a recombinant truncated type VII collagen "minigene". Implication for gene therapy of dystrophic epidermolysis bullosa.
    Chen M; O'Toole EA; Muellenhoff M; Medina E; Kasahara N; Woodley DT
    J Biol Chem; 2000 Aug; 275(32):24429-35. PubMed ID: 10821839
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Type VII collagen is required for Ras-driven human epidermal tumorigenesis.
    Ortiz-Urda S; Garcia J; Green CL; Chen L; Lin Q; Veitch DP; Sakai LY; Lee H; Marinkovich MP; Khavari PA
    Science; 2005 Mar; 307(5716):1773-6. PubMed ID: 15774758
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 23.